| Code | Description | Claims | Beneficiaries | Total Paid |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,955 |
2,794 |
$321K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,888 |
10,000 |
$318K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,141 |
2,810 |
$154K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,501 |
2,353 |
$70K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
923 |
841 |
$42K |
| 87631 |
|
169 |
156 |
$15K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
176 |
173 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
622 |
289 |
$6K |
| 99051 |
|
3,725 |
3,342 |
$6K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
172 |
125 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
56 |
50 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
392 |
364 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
230 |
209 |
$3K |
| 99201 |
|
24 |
20 |
$324.75 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
64 |
62 |
$51.22 |